Genmab — Oktober 2016
-
og en frisk artikel fra kina,fatter dog ingenting selv efter google translate:http://yisheng.china.com.cn/wiki/20161009/617475.html
-
@Solsen. Jeg er enig. De næste par år vil kursudvklingen være drevet af dara salget + resultater af studier med dara i andre indikationer. Derudover er tisotumab + Humax ADC være vigtige, da de er længere fremme end nye molekyler
-
http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002344 Til dem der ikke kan få eftermiddagen til at gå
-
Enig Budweis. Den glemte jeg. Og så selvfølgelig Arzerra i multiple sclerose
-
Der starter aabenbart Revlimid studier i smoldering http://www.myelomabeacon.com/forum/revlimid-smoldering-multiple-myeloma-t7501.html
-
en anden laeser goer dog opmaerksom paa, at Darzalex kann vaere en bedre loesning pga bivirkninger!
-
George, der er 13 hits på en søgning len+smm i ct https://www.clinicaltrials.gov/ct2/results? term=lenalidomide+and+smoldering+myeloma&Search=Search Kunne forstille mig at skribenten er blevet tilbudt studie nr. 3
-
Sorry forkert link. Det her burde være bedre https://www.clinicaltrials.gov/ct2/results?term=lenalidomide+and+smoldering+myeloma&Search=Search
-
Tak Bulder
-
Fint indslag om brug af immun terapi mod lungecancer i Søndagsavisen (DR1) - https://twitter.com/linefedders/status/784318821494509573
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind